Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Katherine A.B. Kellett"'
Publikováno v:
Kellett, K A B, Fisher, K, Aldworth, H & Hooper, N M 2023, ' Proteolysis of the low-density lipoprotein receptor in hepatocytes is mediated by BMP1 but not by other astacin proteases ', FEBS Letters . https://doi.org/10.1002/1873-3468.14667
Bone morphogenetic protein 1 (BMP1), a member of the astacin family of zinc-metalloproteases, proteolytically cleaves the low-density lipoprotein receptor (LDLR) within its ligand-binding domain, reducing the binding and cellular uptake of LDL-choles
Publikováno v:
Clinical and experimental rheumatology. 40(2)
Inclusion body myositis (IBM) is characterised by infiltration of CD8+ T-cells and signs of protein aggregation such as rimmed vacuoles and inclusion bodies. Aggregated proteins include those present in neurodegenerative diseases, and also those invo
Autor:
N. Yi Mok, James Chadwick, Nigel M. Hooper, Colin W. G. Fishwick, Katherine A.B. Kellett, A. Peter Johnson, Eva Casas-Arce
Publikováno v:
Journal of Medicinal Chemistry. 56:1843-1852
β-Secretase (BACE1), the enzyme responsible for the first and rate-limiting step in the production of amyloid-β peptides, is an attractive target for the treatment of Alzheimer's disease. In this study, we report the application of the de novo frag
Autor:
Herbert Baybutt, Isobel J. Whitehouse, Jean Manson, Debbie Brown, Pedro Piccardo, Anthony J. Turner, Carolyn D. Jackson, Heledd H. Griffiths, Nigel M. Hooper, Katherine A.B. Kellett
Publikováno v:
Griffiths, H H, Whitehouse, I J, Baybutt, H, Brown, D, Kellett, K A, Jackson, C D, Turner, A J, Piccardo, P, Manson, J C & Hooper, N M 2011, ' Prion protein interacts with bace1 and differentially regulates its activity towards wild type and swedish mutant amyloid precursor protein ', Journal of Biological Chemistry, vol. 286, no. 38, pp. 33489-33500 . https://doi.org/10.1074/jbc.M111.278556
In Alzheimer disease amyloid-β (Aβ) peptides derived from the amyloid precursor protein (APP) accumulate in the brain. Cleavage of APP by the β-secretase BACE1 is the rate-limiting step in the production of Aβ. We have reported previously that th
Autor:
Natalia Z. Makova, Nigel M. Hooper, Katherine A.B. Kellett, Natalia N. Nalivaeva, Anthony J. Turner, Nikolai D. Belyaev, Caroline Beckett, Timothy J. Revett
Publikováno v:
Journal of Biological Chemistry. 285:41443-41454
Amyloidogenic processing of the amyloid precursor protein (APP) by β- and γ-secretases generates several biologically active products, including amyloid-β (Aβ) and the APP intracellular domain (AICD). AICD regulates transcription of several neuro
Autor:
Colin W. G. Fishwick, James Chadwick, Nigel M. Hooper, A. Peter Johnson, N. Yi Mok, Katherine A.B. Kellett
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 19:6770-6774
A novel series of isatin-based inhibitors of beta-secretase (BACE-1) have been identified using a virtual high-throughput screening approach. Structure-activity relationship studies revealed structural features important for inhibition. Docking studi
Publikováno v:
Prion. 3:190-194
Alzheimer and prion diseases are neurodegenerative disorders characterised by the abnormal processing of amyloid-beta (Abeta) peptide and prion protein (PrP(C)), respectively. Recent evidence indicates that PrP(C) may play a critical role in the path
Autor:
Nigel M. Hooper, J Scott Miners, Patrick G. Kehoe, Isobel J. Whitehouse, Seth Love, Katherine A.B. Kellett, Elizabeth B. C. Glennon
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 4, p e59554 (2013)
PLoS ONE, Vol 8, Iss 4, p e59554 (2013)
The cellular prion protein (PrP(C)) has been implicated in the development of Alzheimer's disease (AD). PrP(C) decreases amyloid-beta (Abeta) production, which is involved in AD pathogenesis, by inhibiting beta-secretase (BACE1) activity. Contactin 5
Autor:
Emma R L C Vardy, Sarah L. Cocklin, A. David Smith, Nigel M. Hooper, Jonathan M. J. Williams, Katherine A.B. Kellett
Publikováno v:
Alzheimer's & Dementia. 6
Autor:
Timothy J. Revett, Natalia N. Nalivaeva, Natalia Z. Makova, Nigel M. Hooper, Katherine A.B. Kellett, Nikolai D. Belyaev, Anthony J. Turner
Publikováno v:
Alzheimer's & Dementia. 6